Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 4, 2010, Pages 482-491

  Zhang, Chun ^a   Hu, Jun Jun ^a   Xia, Min ^a   Boini, Krishna M ^a   Brimson, Christopher ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerulosclerosis; Homocysteine; Membrane microdomains; Oxidative injury; Podocytes

Indexed keywords

BETA CYCLODEXTRIN; CHOLERA TOXIN B SUBUNIT; DESMIN; HOMOCYSTEINE; NEPHRIN; PODOCIN; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; GENE CLUSTER; GENE DISRUPTION; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; LIPID RAFT; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PODOCYTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-CYCLODEXTRINS; BLOTTING, WESTERN; ELECTRON SPIN RESONANCE SPECTROSCOPY; FILIPIN; FLOW CYTOMETRY; HOMOCYSTEINE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PODOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 77950370249     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2009.12.006     Document Type: Article

References (43)

1. Robinson K., Gupta A., Dennis V., Arheart K., Chaudhary D., Green R., Vigo P., Mayer E.L., Selhub J., Kutner M., Jacobsen D.W. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996, 94:2743-2748.
2. Moustapha A., Gupta A., Robinson K., Arheart K., Jacobsen D.W., Schreiber M.J., Dennis V.W. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis. Kidney Int. 1999, 55:1470-1475.
3. Ducloux D., Motte G., Challier B., Gibey R., Chalopin J.M. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J. Am. Soc. Nephrol. 2000, 11:134-137.
4. Chow K., Cheung F., Lao T.T., Karmin O. Effect of homocysteine on the production of nitric oxide in endothelial cells. Clin. Exp. Pharmacol. Physiol. 1999, 26:817-818.
5. Erol A., Cinar M.G., Can C., Olukman M., Ulker S., Kosay S. Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells. Endothelium 2007, 14:157-161.
6. Liu X., Luo F., Li J., Wu W., Li L., Chen H. Homocysteine induces connective tissue growth factor expression in vascular smooth muscle cells. J. Thromb. Haemost. 2008, 6:184-192.
7. Guo H., Lee J.D., Uzui H., Yue H., Wang P., Toyoda K., Geshi T., Ueda T. Effects of heparin on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells. Can. J. Cardiol. 2007, 23:275-280.
8. Papatheodorou L., Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 2007, 9:1941-1958.
9. Yi F., Chen Q.Z., Jin S., Li P.L. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2. Cell. Physiol. Biochem. 2007, 20:909-918.
10. Yi F., dos Santos E.A., Xia M., Chen Q.Z., Li P.L., Li N. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am. J. Nephrol. 2007, 27:262-268.
11. Yi F., Li P.L. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am. J. Nephrol. 2008, 28:254-264.
12. Yi F., Xia M., Li N., Zhang C., Tang L., Li P.L. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 2009, 53:90-96.
13. Sen U., Basu P., Abe O.A., Givvimani S., Tyagi N., Metreveli N., Shah K.S., Passmore J.C., Tyagi S.C. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am. J. Physiol. Renal Physiol. 2009, 297:F410-419.
14. Ortiz A., Marron B., Ramos A. The fate of podocytes in proteinuric nephropathies. Nefrologia 2002, 22:425-431.
15. Tryggvason K., Patrakka J., Wartiovaara J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N. Engl. J. Med. 2006, 354:1387-1401.
16. Greiber S., Munzel T., Kastner S., Muller B., Schollmeyer P., Pavenstadt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Int. 1998, 53:654-663.
17. Eid A.A., Gorin Y., Fagg B.M., Maalouf R., Barnes J.L., Block K., Abboud H.E. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 2009, 58:1201-1211.
18. Whaley-Connell A.T., Chowdhury N.A., Hayden M.R., Stump C.S., Habibi J., Wiedmeyer C.E., Gallagher P.E., Tallant E.A., Cooper S.A., Link C.D., Ferrario C., Sowers J.R. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am. J. Physiol. Renal Physiol. 2006, 291:F1308-1314.
19. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
20. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 2000, 1:31-39.
21. Mundel P., Reiser J., Zuniga Mejia A., Borja H., Pavenstadt G., Davidson R., Kriz W., Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell. Res. 1997, 236:248-258.
22. Yi F., Zhang A.Y., Janscha J.L., Li P.L., Zou A.P. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int. 2004, 66:1977-1987.
23. Qureshi I., Chen H., Brown A.T., Fitzgerald R., Zhang X., Breckenridge J., Kazi R., Crocker A.J., Stuhlinger M.C., Lin K., Cooke J.P., Eidt J.F., Moursi M.M. Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc. Med. 2005, 10:215-223.
24. Jia S.J., Jin S., Zhang F., Yi F., Dewey W.L., Li P.L. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1743-1752.
25. Zhang D.X., Zou A.P., Li P.L. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H605-612.
26. Touyz R.M., Apocynin N.A.D.P.H. oxidase, and vascular cells: a complex matter. Hypertension 2008, 51:172-174.
27. Yang L., Zheng S., Epstein P.N. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity. Free Radic. Res. 2009, 43:174-182.
28. Vignais P.V. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. 2002, 59:1428-1459.
29. Poinas A., Gaillard J., Vignais P., Doussiere J. Exploration of the diaphorase activity of neutrophil NADPH oxidase. Eur. J. Biochem. 2002, 269:1243-1252.
30. Mohazzab K.M., Kaminski P.M., Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 1994, 266:H2568-2572.
31. Meier B., Jesaitis A.J., Emmendorffer A., Roesler J., Quinn M.T. The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct. Biochem. J. 1993, 289(Pt 2):481-486.
32. Castier Y., Brandes R.P., Leseche G., Tedgui A., Lehoux S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ. Res. 2005, 97:533-540.
33. Zhang G., Zhang F., Muh R., Yi F., Chalupsky K., Cai H., Li P.L. Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H483-495.
34. Peshavariya H., Dusting G.J., Di Bartolo B., Rye K.A., Barter P.J., Jiang F. Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic. Res. 2009, 1-11.
35. Kawachi H., Miyauchi N., Suzuki K., Han G.D., Orikasa M., Shimizu F. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton) 2006, 11:274-281.
36. Huber T.B., Benzing T. The slit diaphragm: a signaling platform to regulate podocyte function. Curr. Opin. Nephrol. Hypertens. 2005, 14:211-216.
37. Endlich N., Kress K.R., Reiser J., Uttenweiler D., Kriz W., Mundel P., Endlich K. Podocytes respond to mechanical stress in vitro. J. Am. Soc. Nephrol. 2001, 12:413-422.
38. Uchida K., Suzuki K., Iwamoto M., Kawachi H., Ohno M., Horita S., Nitta K. Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis. Kidney Int. 2008, 73:926-932.
39. Mundel P., Shankland S.J. Podocyte biology and response to injury. J. Am. Soc. Nephrol. 2002, 13:3005-3015.
40. Shankland S.J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006, 69:2131-2147.
41. Isermann B., Vinnikov I.A., Madhusudhan T., Herzog S., Kashif M., Blautzik J., Corat M.A., Zeier M., Blessing E., Oh J., Gerlitz B., Berg D.T., Grinnell B.W., Chavakis T., Esmon C.T., Weiler H., Bierhaus A., Nawroth P.P. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat. Med. 2007, 13:1349-1358.
42. Koshikawa M., Mukoyama M., Mori K., Suganami T., Sawai K., Yoshioka T., Nagae T., Yokoi H., Kawachi H., Shimizu F., Sugawara A., Nakao K. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 2005, 16:2690-2701.
43. Schiffer M., Bitzer M., Roberts I.S., Kopp J.B., ten Dijke P., Mundel P., Bottinger E.P. Apoptosis in podocytes induced by TGF-beta and Smad7. J. Clin. Invest. 2001, 108:807-816.